Wednesday's crackdown by federal regulators on GoodRx highlights increasing efforts by the FTC under activist chair Lina Khan to protect consumers' digital health privacy.
Why it matters: The proposed order could have broad implications for the health tech sector, in which ad-targeting practices — particularly among direct-to-consumer businesses — are nearly ubiquitous.
